The Claim
Physiologically relevant concentrations of β-casomorphin-7 (4–120 µM) increase µ-opioid receptor expression in human intestinal HT29-MTX-E12 cells without significantly altering cell viability, mucus production, or inflammatory cytokine secretion.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human intestinal cells grown in the lab, β-casomorphin-7 at concentrations found in the human body increases the presence of µ-opioid receptors without changing cell survival, mucus output, or inflammatory signals.
See the scientific wording
Physiologically relevant concentrations of β-casomorphin-7 (4–120 µM) increase µ-opioid receptor expression in human intestinal HT29-MTX-E12 cells without significantly altering cell viability, mucus production, or inflammatory cytokine secretion, indicating opioid-like activity without overt cellular toxicity or barrier disruption in this in vitro model.
A peptide from milk binds to intestinal cells and turns on genes that make more opioid receptors, making the cells more sensitive to similar peptides without damaging the cells or triggering inflammation.
What the research says
1 studyWhen gut cells are exposed to a protein fragment from A1 milk at levels you’d actually get from drinking it, they respond like they’re being touched by an opioid — but they don’t get damaged, don’t make more mucus, and don’t get inflamed. So it’s active but not harmful in this lab setup.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.